Bausch Health Companies Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Bausch Health Companies Inc 公司

Bausch Health Companies Inc. 是一家全球多元化制药公司。该公司通过 Bausch + Lomb Corporation 开发、制造和营销主要在胃肠病学 (GI)、肝病学、神经病学和皮肤病学等治疗领域的产品。其 Salix 部门在美国销售 GI 产品。其国际部门在美国和波多黎各以外销售品牌药品、品牌仿制药和其他产品（Bausch + Lomb 产品和 Solta Medical 美容医疗设备的销售除外）。其 Solta Medical 部门在全球销售 Solta Medical 美容医疗设备。其多元化部门在美国销售神经病学和某些其他治疗类别的药品。其 Bausch + Lomb 部门在全球销售 Bausch + Lomb 视力保健、外科和医药产品。

公司简介

公司代码BHC

公司名称Bausch Health Companies Inc

上市日期Sep 20, 1994

CEOMr. Thomas J. Appio

员工数量20700

证券类型Ordinary Share

年结日Sep 20

公司地址2150 St. Elzear Blvd. West

城市LAVAL

上市交易所The Toronto Stock Exchange

国家Canada

邮编H7L 4A8

电话18003611448

网址https://www.bauschhealth.com/

公司代码BHC

上市日期Sep 20, 1994

CEOMr. Thomas J. Appio

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Thomas J. Appio

Chief Executive Officer, Director

627.22K

--

Mr. Jean-Jacques (JJ) Charhon

Executive Vice President, Chief Financial Officer

199.24K

--

Dr. Amy B. Wechsler, M.D.

Independent Director

106.60K

-64.44%

Ms. Aimee J. Lenar

Executive Vice President, US Pharma

25.38K

+212.92%

Mr. Robert N. Power

Independent Director

6.60K

-97.41%

Ms. Sandra Leung

Director

--

-100.00%

Mr. Michael Goettler

Director

--

-100.00%

Mr. John A. Paulson ,

Independent Non-Executive Chairman of the Board

--

Dr. Richard C. Mulligan, Ph.D.

Independent Director

--

Ms. Sarah B. Kavanagh

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Thomas J. Appio

Chief Executive Officer, Director

627.22K

--

Mr. Jean-Jacques (JJ) Charhon

Executive Vice President, Chief Financial Officer

199.24K

--

Dr. Amy B. Wechsler, M.D.

Independent Director

106.60K

-64.44%

Ms. Aimee J. Lenar

Executive Vice President, US Pharma

25.38K

+212.92%

Mr. Robert N. Power

Independent Director

6.60K

-97.41%

Ms. Sandra Leung

Director

--

-100.00%

收入明细

单位: USD更新时间: 7月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Pharmaceutical Products

4.40B

45.67%

Device Products

2.24B

23.27%

OTC

1.90B

19.77%

Branded and Other Generic Products

979.00M

10.17%

Other Product Lines

107.00M

1.11%

地区USD

名称

营收

占比

United States and Puerto Rico

5.77B

59.92%

Other Foreign Countries

1.08B

11.25%

China (Country)

496.00M

5.15%

Canada

402.00M

4.18%

Poland

350.00M

3.64%

其他

1.53B

15.86%

业务

地区

业务USD

名称

营收

占比

Pharmaceutical Products

4.40B

45.67%

Device Products

2.24B

23.27%

OTC

1.90B

19.77%

Branded and Other Generic Products

979.00M

10.17%

Other Product Lines

107.00M

1.11%

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

Paulson & Co. Inc.

19.13%

Meruelo (Alex)

9.94%

GoldenTree Asset Management, LP

9.26%

Nomura Securities Co., Ltd.

5.81%

Healthcare Of Ontario Pension Plan

3.52%

其他

52.33%

持股股东

占比

Paulson & Co. Inc.

19.13%

Meruelo (Alex)

9.94%

GoldenTree Asset Management, LP

9.26%

Nomura Securities Co., Ltd.

5.81%

Healthcare Of Ontario Pension Plan

3.52%

其他

52.33%

股东类型

持股股东

占比

Family Office

19.13%

Investment Advisor/Hedge Fund

14.95%

Individual Investor

10.89%

Research Firm

10.02%

Investment Advisor

7.99%

Hedge Fund

6.23%

Bank and Trust

4.45%

Pension Fund

4.25%

Private Equity

1.42%

其他

20.68%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

518

269.81M

72.96%

-35.70M

2025Q1

547

263.71M

71.37%

-49.89M

2024Q4

568

275.73M

74.96%

-32.06M

2024Q3

627

279.89M

77.25%

-44.78M

2024Q2

703

283.62M

78.54%

-59.67M

2024Q1

764

278.87M

76.11%

-93.72M

2023Q4

801

283.62M

78.55%

-85.16M

2023Q3

821

301.23M

82.72%

-52.06M

2023Q2

836

283.61M

80.53%

-76.52M

2023Q1

862

290.05M

79.80%

-77.57M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Paulson & Co. Inc.

32.79M

8.87%

+6.35M

+24.03%

Jun 13, 2025

Meruelo (Alex)

36.76M

9.95%

+148.73K

+0.41%

Mar 31, 2025

GoldenTree Asset Management, LP

30.25M

8.19%

+2.71M

+9.84%

Mar 31, 2025

Nomura Securities Co., Ltd.

23.39M

6.33%

+12.05M

+106.21%

Mar 31, 2025

Healthcare Of Ontario Pension Plan

13.00M

3.52%

--

Mar 31, 2025

The Vanguard Group, Inc.

11.68M

3.16%

+61.62K

+0.53%

Mar 31, 2025

Maple Rock Capital Partners, Inc.

6.80M

1.84%

+1.50M

+28.25%

Mar 31, 2025

National Bank of Canada

7.51M

2.03%

-7.91M

-51.29%

Mar 31, 2025

SG Americas Securities, L.L.C.

2.87M

0.78%

-431.68K

-13.07%

Mar 31, 2025

MFN Partners Management LP

6.00M

1.62%

--

Mar 31, 2025

持股ETF

更新时间: 8月6日周三

机构名称

占比

Gotham 1000 Value ETF

0.18%

JPMorgan International Value ETF

0.15%

FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF

0.12%

VanEck Pharmaceutical ETF

0.1%

Schwab International Small-Cap Equity ETF

0.08%

DFA Dimensional International Small Cap ETF

0.07%

iShares Intl Small Cap Equity Factor ETF

0.06%

Schwab Fundamental International Equity ETF

0.03%

Invesco RAFI Developed Mkts ex-US ETF

0.03%

DFA Dimensional Intl Sustainability Core 1 ETF

0.01%

Gotham 1000 Value ETF

占比0.18%

JPMorgan International Value ETF

占比0.15%

FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF

占比0.12%

VanEck Pharmaceutical ETF

占比0.1%

Schwab International Small-Cap Equity ETF

占比0.08%

DFA Dimensional International Small Cap ETF

占比0.07%

iShares Intl Small Cap Equity Factor ETF

占比0.06%

Schwab Fundamental International Equity ETF

占比0.03%

Invesco RAFI Developed Mkts ex-US ETF

占比0.03%

DFA Dimensional Intl Sustainability Core 1 ETF

占比0.01%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Bausch Health Companies Inc

6.730USD

Bausch Health Companies Inc

6.730

概览

公司

财务

分析